TNF-α inhibitors are associated with reduced indices of subclinical atherosclerosis in patients with psoriatic disease
Arthritis & Rheumatism Nov 04, 2017
Eder L, et al. - A two-stage study was performed to evaluate the impact of TNF-α inhibitors (TNFi) on subclinical cardiovascular disease in psoriatic patients. It was concluded that the TNFi treatment was related to the decreased progression of carotid plaques in men and improvement in vascular inflammation in psoriatic patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
